1683 related articles for article (PubMed ID: 29289420)
1. Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment.
Whiteside TL
Semin Immunol; 2018 Feb; 35():69-79. PubMed ID: 29289420
[TBL] [Abstract][Full Text] [Related]
2. The effect of tumor-derived exosomes on immune regulation and cancer immunotherapy.
Whiteside TL
Future Oncol; 2017 Dec; 13(28):2583-2592. PubMed ID: 29198150
[TBL] [Abstract][Full Text] [Related]
3. Effect of mesenchymal stem cells-derived exosomes on tumor microenvironment: Tumor progression versus tumor suppression.
Shojaei S; Hashemi SM; Ghanbarian H; Salehi M; Mohammadi-Yeganeh S
J Cell Physiol; 2019 Apr; 234(4):3394-3409. PubMed ID: 30362503
[TBL] [Abstract][Full Text] [Related]
4. Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes.
Jafarzadeh N; Safari Z; Pornour M; Amirizadeh N; Forouzandeh Moghadam M; Sadeghizadeh M
J Cell Physiol; 2019 Apr; 234(4):3697-3710. PubMed ID: 30317554
[TBL] [Abstract][Full Text] [Related]
5. Exosomes from breast cancer cells can convert adipose tissue-derived mesenchymal stem cells into myofibroblast-like cells.
Cho JA; Park H; Lim EH; Lee KW
Int J Oncol; 2012 Jan; 40(1):130-8. PubMed ID: 21904773
[TBL] [Abstract][Full Text] [Related]
6. Potential roles of tumor-derived exosomes in angiogenesis.
Ludwig N; Whiteside TL
Expert Opin Ther Targets; 2018 May; 22(5):409-417. PubMed ID: 29634426
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity.
Harrell CR; Volarevic A; Djonov VG; Jovicic N; Volarevic V
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830312
[TBL] [Abstract][Full Text] [Related]
8. Lung tumor exosomes induce a pro-inflammatory phenotype in mesenchymal stem cells via NFκB-TLR signaling pathway.
Li X; Wang S; Zhu R; Li H; Han Q; Zhao RC
J Hematol Oncol; 2016 Apr; 9():42. PubMed ID: 27090786
[TBL] [Abstract][Full Text] [Related]
9. BCR-ABL1-driven exosome-miR130b-3p-mediated gap-junction Cx43 MSC intercellular communications imply therapies of leukemic subclonal evolution.
Chai C; Sui K; Tang J; Yu H; Yang C; Zhang H; Li SC; Zhong JF; Wang Z; Zhang X
Theranostics; 2023; 13(12):3943-3963. PubMed ID: 37554265
[No Abstract] [Full Text] [Related]
10. Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells.
Lee JK; Park SR; Jung BK; Jeon YK; Lee YS; Kim MK; Kim YG; Jang JY; Kim CW
PLoS One; 2013; 8(12):e84256. PubMed ID: 24391924
[TBL] [Abstract][Full Text] [Related]
11. The Role of Tumor-Derived Exosomes (TEX) in Shaping Anti-Tumor Immune Competence.
Whiteside TL
Cells; 2021 Nov; 10(11):. PubMed ID: 34831276
[TBL] [Abstract][Full Text] [Related]
12. How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive.
Poggi A; Varesano S; Zocchi MR
Front Immunol; 2018; 9():262. PubMed ID: 29515580
[TBL] [Abstract][Full Text] [Related]
13. Carcinoma-Associated Mesenchymal Stem/Stromal Cells: Architects of the Pro-tumorigenic Tumor Microenvironment.
Frisbie L; Buckanovich RJ; Coffman L
Stem Cells; 2022 Aug; 40(8):705-715. PubMed ID: 35583414
[TBL] [Abstract][Full Text] [Related]
14. Exosomal miRNAs in tumor microenvironment.
Tan S; Xia L; Yi P; Han Y; Tang L; Pan Q; Tian Y; Rao S; Oyang L; Liang J; Lin J; Su M; Shi Y; Cao D; Zhou Y; Liao Q
J Exp Clin Cancer Res; 2020 Apr; 39(1):67. PubMed ID: 32299469
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cells in the Tumor Microenvironment.
Atiya H; Frisbie L; Pressimone C; Coffman L
Adv Exp Med Biol; 2020; 1234():31-42. PubMed ID: 32040853
[TBL] [Abstract][Full Text] [Related]
16. Small Extracellular Vesicles Released from Ovarian Cancer Spheroids in Response to Cisplatin Promote the Pro-Tumorigenic Activity of Mesenchymal Stem Cells.
Vera N; Acuña-Gallardo S; Grünenwald F; Caceres-Verschae A; Realini O; Acuña R; Lladser A; Illanes SE; Varas-Godoy M
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600881
[TBL] [Abstract][Full Text] [Related]
17. Exosomes in Cancer: Another Mechanism of Tumor-Induced Immune Suppression.
Whiteside TL
Adv Exp Med Biol; 2017; 1036():81-89. PubMed ID: 29275466
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
[TBL] [Abstract][Full Text] [Related]
19. Exosomes Function in Tumor Immune Microenvironment.
Huang Y; Liu K; Li Q; Yao Y; Wang Y
Adv Exp Med Biol; 2018; 1056():109-122. PubMed ID: 29754177
[TBL] [Abstract][Full Text] [Related]
20. Tumor-Derived Exosomes in Tumor-Induced Immune Suppression.
Hao Q; Wu Y; Wu Y; Wang P; Vadgama JV
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
